Back

Calcium channel blocker and outcomes in patients with heart failure and mildly reduced or preserved ejection fraction

20 May 2023 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Chronic heart failure - treatment 3 Pharmacotherapy HFA Premium Access Heart Failure 2023 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Shingo Matsumoto

Tokai University, Tokyo (Japan)

4 More presentations in this session

Presentation thumbnail
Efficacy of dapagliflozin according to heart rate in patients with heart failure: a patient-level pooled analysis of DAPA-HF and DELIVER
Doctor T. Kondo (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Patient characteristics, outcomes, and effects of dapagliflozin according to the duration of heart failure: a prespecified analysis of the DELIVER trial
Doctor T. Kondo (Nagoya, JP)
Abstract Slides
Presentation thumbnail
Medium term improvement in left ventricular systolic function following CRT pacemaker implantation indicates additional defibrillator component may not be necessary
Doctor H. Shabbir (Blackburn, GB)
Abstract Slides
Presentation thumbnail
Left bundle branch block cardiomyopathy: an intriguing and defiant entity from diagnosis to treatment
Ms C. Oliveira (Porto, PT)
Abstract Slides

Access the full session

Session thumbnail
Chronic heart failure - treatment 3

The Event

Event poster

Heart Failure 2023

20 May - 23 May 2023
You may be interested in
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios
thumbnail
Congress Presentation
Audience Q&A
thumbnail
Congress Presentation
Treating heart failure in adult congenital heart disease: A-Z

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources